Hailan Liu, PA-C, PhD
Clinical Locations
Primary Location
Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111
Advanced Practice Clinician
Physician Assistant
Specialties
Treatment Focus
Survivorship planning for patients with melanoma.
Treatment Philosophy
Where you start your cancer care matters!
I am honored to be part of the surgical oncology team providing care for patients with skin cancer (including melanoma, merkel cell carcinoma, advance squamous cell carcinoma), sarcomas, and gastrointestinal cancers. I treasure my relationship with my patients and thrive to provide the very best care for patients who undergo surgery and throughout the rest of their cancer journey. I follow early stage melanoma patients as well as melanoma survivors in the survivor clinic.
Educational Background
- MS,Physician Assistant Studies, Indiana University, Indianapolis, IN, 2015
- PhD, Pharmacology, Indiana University School of Medicine, Indianapolis, IN, 2008
- BS, Biochemistry, Nanjing University, China, 1998
Certifications
- Physician Assistant Certified
Memberships
- Member, American Society of Clinical Oncology
Honors & Awards
- PA National Honor Society Pi Alpha Inductee, 2015
- KK Chen Award, Department of Pharmacology, Indiana University School of Medicine, 2008
Research Interests
Cancer Survivorship
Selected Publications
Liu, Y.; Liu, H.; Han, B.; Zhang, J.T. Identification of 14-3-3- as a contributor to drug resistance in human breast cancer cells using functional proteomics analysis. Cancer Res.66(6):3248-3255,2006
Liu, H., Liu, Y. and Zhang, J.T. A new mechanism of drug resistance in breast cancer cells: fatty acid synthase overexpression-mediated palmitate overproduction. Mol Cancer Ther. 7(2):263-70,2008
Liu, H., Liu, J., Wu, X and Zhang, J.T. Biochemistry, molecular biology, and pharmacology of fatty acid synthase, an emerging therapeutic target and diagnosis/prognosis marker. Int J Biochem Mol Bio. 1(1): 69–89, 2010
Yang, Y., Liu, H., et al and Zhang, J.T. Role of fatty acid synthase in gemcitabine and radiation resistance of pancreatic cancers. Int J Biochem Mol Biol. 2(1): 89–98, 2011
Liu H., Wu, X. Dong, Z., et al and Zhang, J. T. Fatty acid synthase causes drug resistance by inhibiting TNF-α and ceramide production. J Lipid Res, 54 (3): 776-85, 2013
Gu D., Liu H., Su G., et al and Xie J. Combining Hedgehog signaling inhibition with focal irradiation on reduction of pancreatic cancer metastasis. Mol Cancer Ther. 12(6): 1038-48, 2013
Fan, Q., Gu, D., Liu, H. et al and Xie, J. Defective TGF-β in bone marrow-derived cell prevents Hedgehog-induced skin tumors. Cancer Res. 74(2): 471-83, 2014
Renzetti M, Soliman I, Wu H, Luo B, Liu H, Olszansi A, Movva S, Lango M, Reddy S. Zih F. Farma JM. Evaluation of Molecular Profile in High Risk Class 2 MelanomaDx
Clinical Locations
Primary Location
Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111
Advanced Practice Clinician
Physician Assistant
Specialties
Treatment Focus
Survivorship planning for patients with melanoma.
Treatment Philosophy
Where you start your cancer care matters!
I am honored to be part of the surgical oncology team providing care for patients with skin cancer (including melanoma, merkel cell carcinoma, advance squamous cell carcinoma), sarcomas, and gastrointestinal cancers. I treasure my relationship with my patients and thrive to provide the very best care for patients who undergo surgery and throughout the rest of their cancer journey. I follow early stage melanoma patients as well as melanoma survivors in the survivor clinic.
Education
Educational Background
- MS,Physician Assistant Studies, Indiana University, Indianapolis, IN, 2015
- PhD, Pharmacology, Indiana University School of Medicine, Indianapolis, IN, 2008
- BS, Biochemistry, Nanjing University, China, 1998
Certifications
- Physician Assistant Certified
Memberships
- Member, American Society of Clinical Oncology
Honors & Awards
- PA National Honor Society Pi Alpha Inductee, 2015
- KK Chen Award, Department of Pharmacology, Indiana University School of Medicine, 2008
Research Profile
Research Interests
Cancer Survivorship
Publications
Selected Publications
Liu, Y.; Liu, H.; Han, B.; Zhang, J.T. Identification of 14-3-3- as a contributor to drug resistance in human breast cancer cells using functional proteomics analysis. Cancer Res.66(6):3248-3255,2006
Liu, H., Liu, Y. and Zhang, J.T. A new mechanism of drug resistance in breast cancer cells: fatty acid synthase overexpression-mediated palmitate overproduction. Mol Cancer Ther. 7(2):263-70,2008
Liu, H., Liu, J., Wu, X and Zhang, J.T. Biochemistry, molecular biology, and pharmacology of fatty acid synthase, an emerging therapeutic target and diagnosis/prognosis marker. Int J Biochem Mol Bio. 1(1): 69–89, 2010
Yang, Y., Liu, H., et al and Zhang, J.T. Role of fatty acid synthase in gemcitabine and radiation resistance of pancreatic cancers. Int J Biochem Mol Biol. 2(1): 89–98, 2011
Liu H., Wu, X. Dong, Z., et al and Zhang, J. T. Fatty acid synthase causes drug resistance by inhibiting TNF-α and ceramide production. J Lipid Res, 54 (3): 776-85, 2013
Gu D., Liu H., Su G., et al and Xie J. Combining Hedgehog signaling inhibition with focal irradiation on reduction of pancreatic cancer metastasis. Mol Cancer Ther. 12(6): 1038-48, 2013
Fan, Q., Gu, D., Liu, H. et al and Xie, J. Defective TGF-β in bone marrow-derived cell prevents Hedgehog-induced skin tumors. Cancer Res. 74(2): 471-83, 2014
Renzetti M, Soliman I, Wu H, Luo B, Liu H, Olszansi A, Movva S, Lango M, Reddy S. Zih F. Farma JM. Evaluation of Molecular Profile in High Risk Class 2 MelanomaDx